Constant chain modified bispecific, penta- and hexavalent Ig-M antibodies
US10351631B2 · kind B2 · utility
14Cited by
7References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2014 |
| Grant date | Jul 16, 2019 |
| Priority date | — |
| Expiry date | Sep 4, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/64
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention concerns binding molecules having a penta- or hexameric ring structure, such as, for example, isolated IgM antibodies with five or six bispecific binding units, and methods and means for making and using the same. The invention further concerns multi-specific binding molecules having a penta- or hexameric ring structure, such as, for example, isolated IgM antibodies with five or six bispecific binding units, and methods and means for making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.